Related references
Note: Only part of the references are listed.Targeting Inflammation in Heart Failure with Histone Deacetylase Inhibitors
Timothy A. McKinsey
MOLECULAR MEDICINE (2011)
Epigenetic Repression of Matrix Metalloproteinases in Myofibroblastic Hepatic Stellate Cells through Histone Deacetylases 4 Implication in Tissue Fibrosis
Lan Qin et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Histone Deacetylase: A Potential Therapeutic Target for Fibrotic Disorders
Maoyin Pang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Transforming Growth Factor (TGF)-β Type I Receptor Kinase (ALK5) Inhibitor Alleviates Profibrotic TGF-β1 Responses in Fibroblasts Derived from Peyronie's Plaque
Shuguang Piao et al.
JOURNAL OF SEXUAL MEDICINE (2010)
The Effect of Epigenetic Therapy on Congenital Neurogenic Bladders-A Pilot Study
Steve J. Hodges et al.
UROLOGY (2010)
Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury
Takeshi Marumo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Abrogation of TGF-β1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition
Weichao Guo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Histone Deacetylase 7, a Potential Target for the Antifibrotic Treatment of Systemic Sclerosis
Hossein Hemmatazad et al.
ARTHRITIS AND RHEUMATISM (2009)
IN-1130, a Novel Transforming Growth Factor-beta Type I Receptor Kinase (Activin Receptor-like Kinase 5) Inhibitor, Promotes Regression of Fibrotic Plaque and Corrects Penile Curvature in a Rat Model of Peyronie's Disease
Ji-Kan Ryu et al.
JOURNAL OF SEXUAL MEDICINE (2009)
Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy
Maoyin Pang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-β1-induced renal injury
Hyunjin Noh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis
Asish K. Ghosh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Histone deacetylase 4 is required for TGFβ1-induced myofibroblastic differentiation
Wendy Glenisson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Trichostatin a prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis
Lars C. Huber et al.
ARTHRITIS AND RHEUMATISM (2007)
Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie's disease
Simone M. Haag et al.
EUROPEAN UROLOGY (2007)
Surgical treatment of Peyronie's disease: A critical analysis
Ates Kadioglu et al.
EUROPEAN UROLOGY (2006)
A critical analysis of nonsurgical treatment of Peyronie's disease
Ekkehard W. Hauck et al.
EUROPEAN UROLOGY (2006)
Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis
IV Gregoretti et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Peyronie's disease: A review
SS Gholami et al.
JOURNAL OF UROLOGY (2003)
Gene expression in Peyronie's disease
NF Gonzalez-Cadavid et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2002)
Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-β1-induced fibrogenesis in skin fibroblasts
K Rombouts et al.
EXPERIMENTAL CELL RESEARCH (2002)
Share Paper
